Evidence map›Paper›PMID 31225916›Full record

ArticleEnvironmental toxicology and chemistry2019

Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters.

Jürg Oliver Straub, Rik Oldenkamp, Thomas Pfister, Andreas Häner

Open access · hybridAbstract read
In one paragraph

Article in Environmental toxicology and chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The potential ecological risk of veterinary pharmaceuticals from swine wastewater on freshwater aquatic environment.Water environment research : a research publication of the Water Environment Federation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Jürg Oliver StraubGroup Safety, Health, and Environmental Protection, F.Hoffmann-La Roche, Basle, Switzerland.ORCID 0000-0002-7341-5165
Rik OldenkampDepartment of Environmental Science, Radboud University Nijmegen, Nijmegen, The Netherlands.
Thomas PfisterGroup Safety, Health, and Environmental Protection, F.Hoffmann-La Roche, Basle, Switzerland.
Andreas HänerGroup Safety, Health, and Environmental Protection, F.Hoffmann-La Roche, Basle, Switzerland.
Roche (Switzerland) · CHRadboud University Nijmegen · NL

Funding

F.Hoffmann-La RocheInnovative Medicines Initiative iPiE programme Innovative Medicines Initiative Joint Undertaking
6 · The paper itself

Abstract

An environmental risk assessment is presented for mycophenolic acid (MPA), an immunosuppressive pharmaceutical used for prevention of organ rejection, and its prodrug mycophenolate mofetil (MPM). Mycophenolic acid will not significantly adsorb to activated sludge. In activated sludge,

Indexed as

Environmental MonitoringRisk AssessmentAnimalsAquatic OrganismsChlorophytaDrug Resistance, MicrobialEuropeFishesHumansModels, TheoreticalMycophenolic AcidSewageToxicity TestsWater Pollutants, ChemicalMycophenolic AcidSewageWater Pollutants, ChemicalEcotoxicologyEnvironmental fateEnvironmental risk assessmentMycophenolate mofetilMycophenolic acid

Identifiers

PMID31225916
PMCPMC6856805
OpenAlexW2949731953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.